Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression The enrollment goal of 125 patients was met. Median age was 46 years (range, 21-65 years), ...
Long-term follow-up of metastatic renal cancer patients undergoing reduced-intensity allografting No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2009 ...
Clinical, Economic Benefits of Pegfilgrastim Biosimilars as Prophylactic Against Febrile Neutropenia
In patients with intermediate- to high-risk, use of pegfilgrastim biosimilars could optimize management of FN risk. Use of biosimilar pegfilgrastim as a prophylaxis in patients with cancer and a high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback